Exchange Transfusion

Related Subjects: |Sickle Cell Disease |Acute Chest Syndrome (Sickle Cell) |Exchange Transfusion

🔄 Exchange transfusion is a procedure in which part of a patient’s blood is removed and replaced with donor blood or donor blood components. 🎯 The aim is to remove a harmful circulating factor or abnormal blood component while replacing it with safer or more functional blood. 👩‍⚕️ It is a specialist procedure performed in hospital with close monitoring, usually involving haematology, transfusion, and sometimes critical care support.

📘 What exchange transfusion is used for

• To remove abnormal red cells or reduce the proportion of a harmful red cell population.
• To replace dysfunctional blood components with donor components.
• To reduce the circulating burden of a substance or factor that is contributing to acute illness.
• To achieve a therapeutic effect more quickly than a simple transfusion alone.

🧠 General principle

Unlike a simple transfusion, which mainly adds donor blood, exchange transfusion both removes part of the patient’s circulating blood and replaces it. This allows treatment without simply raising the haemoglobin or circulating volume excessively. The exact target depends on the indication, but the core idea is always the same: remove what is harmful, replace what is helpful.

📊 Common Indications & Notes

🧾 Before the procedure

• Confirm the indication and therapeutic goal with the specialist team.
• Explain the procedure, risks, benefits, and alternatives where possible.
• Check baseline bloods: full blood count, renal function, liver function, group and save, and crossmatch.
• Document baseline observations: pulse, blood pressure, respiratory rate, oxygen saturation, temperature.
• Review fluid status, cardiovascular status, and the need for higher-level monitoring.
• Arrange appropriately matched donor blood/components through the transfusion laboratory.

🩸 Blood product preparation

• Donor units are selected according to the patient’s blood group and clinical requirements.
• Additional matching or special product requirements may be needed depending on the indication and transfusion history.
• The exact component used may vary: red cells, plasma, or other blood components according to the purpose of the exchange.

🧵 Vascular access

• Good large-bore peripheral access may be sufficient in some cases.
• Some procedures require central venous access, especially if flow rates need to be high or prolonged exchange is planned.
• Access should be secure before starting because blood will be repeatedly removed and replaced during the procedure.

⚙️ How the procedure is performed

• Automated exchange (apheresis):
  • A machine withdraws blood from the patient.
  • The machine separates the blood into components.
  • The target component is removed, and the rest is returned along with donor replacement blood/components.
  • This method is usually more precise and allows tighter control of targets and fluid balance.
• Manual exchange:
  • Blood is removed in small staged aliquots.
  • Each removed volume is replaced with donor blood/components and sometimes additional fluid according to protocol.
  • This is less precise than automated exchange but may be used where apheresis is unavailable.

📊 Monitoring during the procedure

• Continuous or frequent observations: pulse, blood pressure, oxygen saturation, respiratory rate, temperature.
• Watch for fluid overload or hypotension as blood is removed and replaced.
• Monitor symptoms: chest pain, dyspnoea, rigors, rash, back pain, anxiety, light-headedness.
• Repeat blood tests may be needed during or after the exchange to assess whether the target has been achieved.

🎯 Treatment targets

• The target depends on the underlying condition.
• Examples include reducing the proportion of an abnormal blood component, improving oxygen-carrying capacity, or removing a pathological circulating factor.
• The specialist team will define the desired endpoint before the procedure begins.

⚠️ Risks and complications

• Transfusion reactions — acute or delayed.
• Alloimmunisation in patients who require repeated transfusions.
• Hypotension or haemodynamic instability during exchange.
• Fluid overload or electrolyte disturbance.
• Line-related complications such as infection, thrombosis, or bleeding if central access is used.
• Citrate-related effects such as tingling or hypocalcaemia during automated procedures.

🩺 After the procedure

• Recheck observations and clinical status.
• Repeat relevant blood tests to confirm the therapeutic target has been reached.
• Continue monitoring for transfusion reactions or delayed complications.
• Document the indication, volume exchanged, blood products used, response, and any adverse events.

🧠 Clinical Pearl

Exchange transfusion is different from simple transfusion because it both removes and replaces blood. This makes it useful when the goal is not just to add oxygen-carrying capacity, but to actively reduce a harmful circulating component while avoiding excessive viscosity or volume overload.